Jbm (Healthcare) Ltd
HKEX:2161

Watchlist Manager
Jbm (Healthcare) Ltd Logo
Jbm (Healthcare) Ltd
HKEX:2161
Watchlist
Price: 2.78 HKD 0.36% Market Closed
Market Cap: 2.3B HKD

Jbm (Healthcare) Ltd
Cost of Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jbm (Healthcare) Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Jbm (Healthcare) Ltd
HKEX:2161
Cost of Revenue
-HK$368.6m
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Cost of Revenue
-HK$5B
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-10%
U
United Laboratories International Holdings Ltd
HKEX:3933
Cost of Revenue
-ÂĄ7.4B
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
-6%
Sino Biopharmaceutical Ltd
HKEX:1177
Cost of Revenue
-ÂĄ5.6B
CAGR 3-Years
12%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Cost of Revenue
-HK$219.7B
CAGR 3-Years
-1%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Cost of Revenue
-$336.3m
CAGR 3-Years
-7%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
No Stocks Found

Jbm (Healthcare) Ltd
Glance View

Market Cap
2.3B HKD
Industry
Pharmaceuticals

JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 274 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

Intrinsic Value
4.35 HKD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Jbm (Healthcare) Ltd's Cost of Revenue?
Cost of Revenue
-368.6m HKD

Based on the financial report for Mar 31, 2025, Jbm (Healthcare) Ltd's Cost of Revenue amounts to -368.6m HKD.

What is Jbm (Healthcare) Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-14%

Over the last year, the Cost of Revenue growth was -19%. The average annual Cost of Revenue growth rates for Jbm (Healthcare) Ltd have been -15% over the past three years , -14% over the past five years .

Back to Top